ABBOTT PARK, Ill., March 6, 2018 /PRNewswire/ — Abbott today announced the U.S. Food and Drug Administration (FDA) approved the Masters HP™ 15mm rotatable mechanical heart valve, the world’s smallest mechanical heart valve, that will allow doctors to treat babies and toddlers in need of a mitral or aortic valve replacement. Until […]
Author: Ken Dropiewski
4C Medical’s Transcatheter Mitral Valve Technology Receives First Place in Cardiovascular Research Technologies 2018 Competition
BROOKLYN PARK, Minn., March 7, 2018 /PRNewswire/ — 4C Medical Technologies, Inc. (4C Medical), a developer of minimally invasive technologies for structural heart disease, today announced that AltaValve™, its medical device for mitral regurgitation (MR), was awarded first place in the Cardiovascular Research Technologies (CRT) competition held March 3-6, 2018 in Washington, DC. “AltaValve will answer […]
FDA expands approval of replacement heart valve, smallest mechanical valve size approved in the world
SILVER SPRING, Md., March 6, 2018 /PRNewswire-USNewswire/ — The U.S. Food and Drug Administration today expanded the approval of a heart valve to include a size small enough to be used in newborn pediatric patients to treat heart defects. Specifically, the agency approved the Masters Series Mechanical Heart Valve with […]
HeartFlow Announces Collaborative Research Agreement with Imperial College London
REDWOOD CITY, Calif.–(BUSINESS WIRE)– HeartFlow, Inc. today announced that it has entered into a collaborative research agreement with Imperial College London. The collaboration will enable experts from HeartFlow and Imperial to work side-by-side on joint projects in the areas of medical imaging and deep learning. The company’s non-invasive HeartFlow® FFRct Analysis leverages deep […]
Cardiovascular Systems Presents LIBERTY 360° 18-Month Outcomes at CRT18 Interventional Cardiology Conference
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, presented 18-month outcomes from its LIBERTY 360° study at the Cardiovascular Research Technologies (CRT) 2018 interventional cardiology conference in Washington, D.C. The […]
Endologix, Inc. Announces Enrollment of the First Patient in EVAS2 IDE Clinical Study of the Nellix® EndoVascular Aneurysm Sealing System
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the first patient was treated in the EVAS2 IDE Confirmatory Clinical Study of the investigational Nellix® EndoVascular Aneurysm Sealing (EVAS) System by Sajjad M. Hussain, M.D., Chief of the Department of Vascular Surgery […]
Symic Bio Announces Results of Locally-Administered Therapeutic SB-030 in Preclinical Model of Vascular Intervention
SAN FRANCISCO, March 5, 2018 /PRNewswire/ — Symic Bio, a biopharmaceutical company developing novel extracellular matrix targeting drugs, today announced results from a preclinical study of locally-applied therapeutic SB-030 in the reduction of inflammatory response and clot formation. In a porcine arteriovenous shunt model for vascular procedures such as bypass grafts and angioplasty, […]
Philips introduces next generation of IntelliSpace Cardiovascular informatics platform at HIMSS 2018
Comprehensive informatics and imaging solution features enhanced security protocols to meet industry-leading standards Improved interoperability and standardization increases scalability across the hospital enterprise to help improve efficiency and quality AMSTERDAM and LAS VEGAS, March 5, 2018 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of IntelliSpace Cardiovascular 3.1, […]
Corindus Receives FDA Clearance for First Automated Robotic Movement in technIQ™ Series for CorPath GRX Platform
WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the first automated robotic movement designed for the CorPath GRX platform. The proprietary software feature, named “Rotate on Retract” […]
Nihon Kohden Launches Aireeg® WEE-1200 Wireless EEG System at HIMSS18
IRVINE, Calif.–(BUSINESS WIRE)– Nihon Kohden Corporation, a U.S. market leader in precision medical products and services, has launched its aireeg®WEE-1200 wireless electroencephalogram (EEG) system designed specifically for patient comfort and easy access to real-time patient data during long-term epilepsy monitoring, intensive care, and routine EEG environments. The smart, safe and secure […]



